Beta Drugs Limited
Beta Drugs Limited has informed the Exchange about the acquisition of 66.09% stake in Nivian Lifesciences Private Limited. |SUBJECT: General Updates
Beta Drugs Limited has informed the Exchange about the acquisition of 66.09% stake in Nivian Lifesciences Private Limited. |SUBJECT: General Updates
NURECA LIMITED has informed the Exchange about Board Meeting to be held on 17-Jan-2026 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2025 and Other business.…
Aequs Limited has informed the Exchange regarding a press release dated January 10, 2026, titled “Rajeev Kaul Recognized as Co-Founder of Aequs Limited”. |SUBJECT: Press Release
NURECA LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
AVENUE SUPERMARTS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |SUBJECT: Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
Ratnaveer Precision Engineering Limited has informed the Exchange regarding Proceedings of Extraordinary General Meeting held on January 10, 2026 |SUBJECT: Shareholders meeting
Capital India Finance Limited has informed the Exchange about renewal of license |SUBJECT: Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals
Integra Essentia Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025. |SUBJECT: Outcome of Board Meeting
ABM International Limited has informed the Exchange about General Updates |SUBJECT: General Updates
Rajgor Castor Derivatives Limited has informed the Exchange about Certificate in the matter of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st December, 2025. |SUBJECT: Certificate under SEBI (Depositories…